Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Long-Term Deferred Tax (2024 - 2026)

Inspire Medical Systems' Long-Term Deferred Tax history spans 3 years, with the latest figure at $87.7 million for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $87.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $87.7 million, a N/A change, with the full-year FY2025 number at $88.7 million, up 681953.85% from a year prior.
  • Long-Term Deferred Tax hit $87.7 million in Q1 2026 for Inspire Medical Systems, down from $88.7 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for INSP hit a ceiling of $88.7 million in Q4 2025 and a floor of $13000.0 in Q4 2024.
  • Historically, Long-Term Deferred Tax has averaged $58.8 million across 3 years, with a median of $87.7 million in 2026.
  • The widest YoY moves for Long-Term Deferred Tax: up 681953.85% in 2025, down 681953.85% in 2025.
  • Tracing INSP's Long-Term Deferred Tax over 3 years: stood at $13000.0 in 2024, then surged by 681953.85% to $88.7 million in 2025, then decreased by 1.13% to $87.7 million in 2026.
  • Business Quant data shows Long-Term Deferred Tax for INSP at $87.7 million in Q1 2026, $88.7 million in Q4 2025, and $13000.0 in Q4 2024.